unc-129 was first identified as a gene influencing axon guidance in C. elegans . The uncoordinated phenotype observed in
unc-129 mutant animals results from defects in axon guidance of the DA, DB, VD and DD commissural classes of motorneurons. Cloning of the
unc-129 gene showed that it encodes a TGF-beta ligand that functions in dorsal muscles to mediate axon guidance. Biochemical characterization confirmed that
unc-129 is processed and dimerized, consistent with its identification as a TGF-beta ligand. TGF-beta ligands act through heterodimers of type I and type II serine threonine kinase receptors. In C. elegans there are two characterized TGF-beta pathways, one affecting body size and male tail formation, the other regulating dauer formation. These pathways use distinct type I receptors, SMA-6 and DAF-1, but share a common type II receptor (DAF-4). No other TGF-beta receptors have been identified in the genome sequence. Mutations in these receptors as well as their downstream mediators, the SMADs, have not been reported to result in uncoordinated phenotypes. In order to explore the possibility that
unc-129 acts through known TGF-beta receptors, we examined receptor mutants for the presence of axon guidance defects. Mutations in the TGF-beta receptors did not cause axon guidance defects. Furthermore, a double mutant of the type I receptors,
sma-6 and
daf-1, did not display defects in axon guidance. These data suggest that UNC-129 does not act through the traditional type I and II receptors. In order to identify downstream mediators of
unc-129 , we began a mutagenesis screen for suppressors of ectopic
unc-129 . Ectopic expression of
unc-129 in both dorsal and ventral muscles, which occurs in an
unc-130 mutant, results in distal tip cell (DTC) migration defects. These defects are suppressed by mutations in
unc-129 , which, on their own do not cause DTC defects. This suggests that defects in components of the
unc-129 signaling pathway should suppress the DTC defects induced by ectopic
unc-129 expression. Expression of
unc-129 in both dorsal and ventral muscles using the
myo3 promoter to drive expression also results in defects in distal tip cell (DTC) migration, mimicking the
unc-130 mutant phenotype. In principle, defects in components of the
unc-129 signaling pathway should suppress the DTC defects of
myo-3::
unc-129 transgenic animals. Using a small scale F2 screen, we have isolated 7 mutations that suppress the DTC migration defects of
myo-3::
unc-129 transgenic animals. These mutants do not display defects in body size, male tail formation or dauer formation.